Navigation Links
AMDL Announces Teleconference to Discuss Its Second Quarter 2008 Financial Results
Date:8/15/2008

TUSTIN, Calif., Aug. 15 /PRNewswire-FirstCall/ -- (http://www.amdl.com) AMDL Inc. (Amex: ADL), a world leader in specialty pharmaceuticals with operations in Shenzhen, Jiangxi and Jilin China, announced today its chief executive officer Gary Dreher and chief financial officer Akio Ariura will host a teleconference to discuss the Company's second quarter 2008 financial results. The call is scheduled for Tuesday, August 19, 2008 at 1:45 p.m. Pacific Standard Time (4:45 p.m. Eastern Time).

Existing or potential investors who would like to submit questions prior to the call can do so by emailing Kristine Szarkowitz at kszarkowitz@amdl.com.

To access the live call, please dial (877) 360-1705 in the U.S. or (706) 902-3245 outside the U.S. and reference Conference ID# 60855707 five minutes before the call begins. The conference call script will also be available on the Investor section of the AMDL web site located at http://www.amdl.com. Click on "Investor Relations" then "Recent News" to access the Company's earnings release which was issued today, August 15, 2008, and all other accompanying financial and operating information.

About AMDL:

AMDL Inc. is a global specialty pharmaceutical company. The company is headquartered in Tustin, California with operations in Shenzhen, Jiangxi, and Jilin, China. Along with its subsidiary Jade Pharmaceutical Inc. (JPI), AMDL is devoted to the research, development, manufacture, and marketing of diagnostic, pharmaceutical, nutritional supplement, and cosmetic products currently in China. The company employs approximately 320 people in the U.S. and China. More information about AMDL and its products can be obtained at http://www.amdl.com.

About Jade Pharmaceutical:

JPI has access to the fastest growing pharmaceutical and consumer market in the world -- China. AMDL, through its Jade subsidiaries, currently holds licenses for 133 products that are manufactured as large volume injection fluids, tablets and other related products. It currently manufactures over 20 key generic, over-the-counter and supplemental pharmaceutical products under certified Chinese Good Manufacturing Practice (CGMP) standards.

AMDL Contact:

Kristine Szarkowitz

Director-Investor Relations

kszarkowitz@amdl.com

(M) (206) 310-5323


'/>"/>
SOURCE AMDL
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Watson Announces District Court Ruling in Naproxen Sodium Patent Suit
2. Sun Pharma Announces U.S. FTC Clearance for Taro Tender Offer
3. Pregis Announces Second Quarter 2008 Financial Results
4. WuXi PharmaTech Announces Second Quarter 2008 Results
5. Assurant Announces Two Executive Appointments
6. Lotus Pharmaceuticals Announces Conference Call to Discuss Second Quarter 2008 Results
7. Wound Management Technologies, Inc. Announces Clarification of Eprint Viewing of Case Report in Advances in Skin and Wound Journal
8. Westaim announces 2008 second quarter results
9. Care Investment Trust Inc. Announces an Agreement in Principle for CIT Healthcare to Purchase Mortgage Assets and Reduce Management Fee
10. Barr Announces Agreements to Settle Mirapex(R) and Aggrenox(R) Patent Challenges
11. American HealthChoice Announces Launch of OmniBody Scan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced ... feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as a ... has released tools for healthy coping following a traumatic event. , Trauma sufferers tend ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are ... for this recognition are considered among the top 2 percent of lawyers practicing within ... of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, ...
(Date:6/24/2016)... TX (PRWEB) , ... June 24, 2016 , ... People ... part in Genome magazine’s Code Talker Award, an essay contest in which patients and ... an award to be presented at the 2016 National Society of Genetic Counselors (NSGC) ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the Frederick area economy by obtaining investment capital for emerging technology companies. ... years that have already resulted in more than a million dollars of capital ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical Systems ... "Company"), which develops, markets and sells medical devices and ... , signed a strategic cooperation agreement with Hongyuan Supply ... Supply Chain") on June 20, 2016, to develop Dehaier,s ... strategic cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s ...
(Date:6/24/2016)... , June 24, 2016 VolitionRx ... of Dr. Edward Futcher to the ... effective June 23, 2016.Dr. Futcher was also appointed ... Governance Committees.  As a non-executive member of the ... and strategic counsel to VolitionRx in connection with ...
Breaking Medicine Technology: